Skip to content

Author

Ibrahim Khalil

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 8806: Comparative Efficacy of GLP-1 Receptor Agonists versus SGLT-2 Inhibitors for Limb Outcomes in Patients with Peripheral Artery Disease: A Multicenter Propensity Score-Matched Real-World Study

Background: Patients with peripheral artery disease (PAD) face high risks of limb loss, revascularization, and cardiovascular events. While both GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors (SGLT-2is) improve cardiovascular outcomes in type 2 diabetes, their comparative effectiveness on limb-specific ou...

Ibrahim Khalil, Pallab Sarker, M. Hossain et al. · 0 citations
Review Nov 2026

Abstract 16942: Cardiovascular Outcomes of Very Low LDL-Cholesterol Achieved versus Higher Levels in Patients with Established Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Current guidelines recommend an LDL-cholesterol (LDL-C) target below 55 mg/dL for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD). Yet, outcomes-based evidence directly validating this target relative to higher levels remains limited. Research Question: Does achieving ve...

Fareeha Shahid, Aizaz Anwar Khalid, Fawaz ur Rehman et al. · 0 citations
Open access Sep 2026

Prevalence and associated factors of burnout among postgraduate trainee physicians in Bangladesh: a multicentre cross-sectional study

Abstract Objectives This study aimed to determine the prevalence of burnout and its associated factors among postgraduate trainee physicians in Bangladesh. Design A multicentre cross-sectional study. Setting Three public tertiary-care academic institutions across the country (Dhaka Medical College Hospital, Chittagong...

Mohammad Jahid Hasan, T. Tabassum, A. S. Khan et al. · 0 citations
Open access Sep 2026

Temporal Trends, Cross-Country Inequality, and Future Burden of Mortality and DALYs Attributable to High Fasting Plasma Glucose in South Asia, 1990–2050: Forecasting, Validation, and Benchmarking Analysis Using the Global Burden of Disease 2023 Study

Background & Objective: High fasting plasma glucose (HFPG) is a major modifiable metabolic risk factor for cardiovascular disease, chronic kidney disease, premature mortality, and disability. South Asia faces a growing cardiometabolic burden, yet long-term country-level trends, inequalities, and future HFPG-attributabl...

Muhammad Shoaib Khan, Suleman Khan, Safia Wazir et al. · 0 citations
Open access Sep 2026

National trends in heart failure and hyperlipidemia related mortality in the United States, 1999–2024

Cardiovascular disease remains the leading cause of death in the United States, with heart failure (HF) and hyperlipidemia substantially contributing to mortality. This study aimed to examine national trends in HF-related mortality with coexisting hyperlipidemia from 1999 to 2024 and project future mortality patterns t...

B. Ayalew, D. N. Smith, Laksh Kumar et al. · 0 citations
Open access Aug 2026

Epidemiological trends and sex disparities in stroke disability-adjusted life years and mortality in Middle East and North Africa (MENA)

Stroke remains a leading cause of disability and mortality globally, with pronounced burdens in the Middle East and North Africa (MENA) due to demographic shifts, conflict, and varying healthcare access. This study analyzes temporal trends and sex disparities in stroke-related disability-adjusted life years (DALYs) and...

Ibrahim Khalil, Mohamed Wagdy, Ghassan Adnan Hashim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.